Streetbeat News

Products Services

AMD

AMD has introduced its new Ryzen Threadripper 7000 Series Processors and Ryzen Threadripper PRO 7000 WX-Series Processors. The new processors are expected to enhance the company's product portfolio and strengthen its market position.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 1:06 pm

PTPI

Petros Pharmaceuticals has initiated a self-selection (Phase 2-equivalent) study for its erectile dysfunction drug, STENDRA.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 1:05 pm

NVO

The European Medicines Agency and the UK's Medicines and Healthcare Products Regulatory Agency have warned about fake pre-filled pens of Novo Nordisk's diabetes drug Ozempic being found at wholesalers in the EU and UK. There is no evidence that any of these falsified pens have been dispensed to patients. Novo Nordisk recently raised its FY23 guidance due to surging sales of its obesity and weight-loss drugs.

Portfolio Pulse from Vandana Singh

October 19, 2023 | 12:57 pm

GDYN

Grid Dynamics Holdings, Inc. (NASDAQ:GDYN) has introduced its Generative AI Product Data Starter Kit, aimed at automating product catalog attribution and creating engaging product names and descriptions at scale. The kit addresses challenges in e-commerce by improving product attribution processes and creating personalized, on-brand product data. It also translates product data into multiple languages, enhancing customer acquisition and retention, and increasing revenue.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 12:50 pm

GRI

GRI Bio has presented translational data demonstrating a connection between NKT cells and the pathogenesis of Idiopathic Pulmonary Fibrosis (IPF) at the 2023 Pittsburgh-Ireland International Lung Conference. The company is on track to launch a Phase 2a biomarker study for its lead program, GRI-0621, a type 1 invariant NKT (iNKT) antagonist for the treatment of IPF, before the end of the year.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 12:50 pm

AAPL

According to industry sources, the upcoming 12.9-inch iPad Air may feature conventional LCD backlighting instead of MiniLED backlighting, as reported by DigiTimes Alert.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 12:48 pm

RHHBY

Roche Holdings AG reported a 1% increase in nine-month sales to CHF 44.1 billion, despite a significant drop in sales of COVID-19 products and biosimilar erosion. Excluding COVID-19 products, Group sales grew by 9%. The company expects a decrease in group sales and adjusted earnings per share in the low single-digit percentage range in 2023. Roche predicted a decline in sales of COVID-19 products of about CHF 4.5 billion. The Diagnostics Division achieved sales of CHF 10.4 billion, a decrease of 18% due to a drop in demand for COVID-19 tests.

Portfolio Pulse from Vandana Singh

October 19, 2023 | 12:46 pm

AENT

Alliance Entertainment (AENT) reported Q4 fiscal 2023 net revenues of $247M, a decrease of 7% compared to the same period in 2022. The company's gross profit increased by 6% to $30.2M, and net loss was $1.7M, compared to a net loss of $4.6M in 2022. The company also highlighted several operational achievements, including a $4M public offering, partnerships with Future Today and Atari, and record-breaking vinyl sales on Record Store Day. Despite economic challenges, the company sees opportunities for growth through acquisitions, enhancing DTC relationships, and expanding product offerings.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 12:45 pm

GILD

PFE

Pfizer Inc is planning to increase the price of its Covid-19 drug Paxlovid to $1,390 for a five-day course, more than double the initial price paid by the U.S. government. This decision has been criticized by doctors and patient advocates due to concerns about patient access. Pfizer defended the price increase, stating it reflects the value Paxlovid provides in reducing Covid-19-related hospitalizations and deaths. The company also plans to offer discounts to uninsured patients or those covered by Medicaid.

Portfolio Pulse from Vandana Singh

October 19, 2023 | 12:45 pm

NFLX

Netflix Inc. (NASDAQ:NFLX) has decided to discontinue its Basic plan in several countries, including Australia. The change will affect new and returning subscribers, but current users will retain their existing plans. The company plans to initiate the same changes in Germany, Spain, Japan, Mexico, Australia, and Brazil next week. This decision follows Netflix's strong Q3 results, where it reported a 7.8% YoY increase in revenue to $8.54 billion.

Portfolio Pulse from Benzinga Neuro

October 19, 2023 | 12:43 pm